Publicaciones RedinRen

• The Role of New Immunosuppressive Drugs in Nonmelanoma Skin Cancer in Renal Transplant Recipients.

  Bernat-García J, Morales Suárez-Varela M, Vilata-Corell JJ, Marquina-Vila A, Pallardo L, Crespo J.. Actas Dermosifiliogr. 2014;:314-317.

• Diagnosis of acute cortical necrosis in renal transplantation by contrast-enhanced ultrasound: a preliminary experience.

  Fernandez CP, Ripolles T, Martinez MJ, Blay J, Pallardó L, Gavela E. Ultraschall Med. 2013 Aug;34(4):340-4.

• Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region.

  Bernat García J, Morales Suárez-Varela M, Vilata JJ, Marquina A, Pallardó L, Crespo J. Acta Derm Venereol. 2013 Jul 6;93(4):422-7.

• Urinary neutrophil gelatinase-associated lipocalin after kidney transplantation: is it a good biomarker to assess delayed graft function?

  Kanter J, Beltran S, Molina D, Vallecillo J, Sancho A, Gavela E. Transplant Proc. 2013 May;45(4):1368-70.

• Response.

  Kanter J, Sancho A, Gavela E, Pallardo LM, Fernandez C. Transplant Proc. 2013 Jan-Feb;45(1):447-8.

• The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study.

  Molina P, Górriz JL, Molina MD, Peris A, Beltrán S, Kanter J. Nephrol Dial Transplant. 2014 Jan;29(1):97-109.

• Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.

  Kanter Berga J, Sancho Calabuig A, Gavela Martinez E, Puig Alcaraz N, Beltran Catalan S, Avila Bernabeu A. Transplant Proc. 2012 Nov;44(9):2529-31.

• Advances in immunosuppression for kidney transplantation: new strategies for preserving kidney function and reducing cardiovascular risk.

  Bestard O, Campistol JM, Morales JM, Sánchez-Fructuoso A, Cabello M, Cabello V. Nefrologia. 2012 May 14;32(3):374-84.